Associated Papers
Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.
Takeshita T et al.
Esmo Open, 2024
38387111 (PubMed )
Supplement: mmc2.xlsx › Baseline
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing.
Fernandez SV et al.
International Journal of Molecular Sciences, 2023
37958763 (PubMed )
Supplement: ijms-24-15779-s001.zip › ijms-2681168-supplementary.pdf
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).
Vanni I et al.
Diagnostic Pathology, 2020
33317587 (PubMed )
Supplement: 13000_2020_1052_MOESM3_ESM.xlsx › Supplementary_Table_3
Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.
Li J et al.
Gut, 2020
Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling.
Weber S et al.
Cancers, 2020
32560092 (PubMed )
Supplement: cancers-12-01588-s001.zip › Table_S4.xlsx › Table_S4
Select a paper to view details